Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 154 participants.

Also called NCT03440268

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 154 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03440268
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03440268. Randomized; double masking; primary purpose prevention. Start 2018-03-15 (anticipated); primary completion 2019-03-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
Condition
Surgery--Complications
Condition
Cardiac Valve Disease
Condition
Oxygen Radical Damage
Condition
Post-Op Complication
Intervention (Drug)
N Acetyl Cysteine
Intervention (Drug)
Placebos
Lead sponsor
University of Sao Paulo General Hospital (class: other)

Record details

Record id
cardio:ct-nct03440268
Content hash
3a1e3a52b8864939fa64dcc242ebf934acb0da06fbf3f8a4f2e612cee6dc06c4